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Regulation of Murine Cerebral Malaria
Pathogenesis by CD1d-Restricted NKT Cells
and the Natural Killer Complex
larly in the developmental stages, the murine disease is
accepted to reflect the cytokine-dependent inflamma-
tory cascade contributing to cerebral and systemic
involvement in humans. In the P. berghei ANKA cerebral
malaria syndrome, causal roles for tumor necrosis fac-
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et al., 1989) and polyclonal anti-TNF- (Grau et al., 1987).University of Western Australia
Nedlands, Western Australia 6907 Mutant mice lacking TNF/ (Rudin et al., 1997a),
lymphotoxin- (LT-) (Engwerda et al., 2002), IFN-Australia
(Rudin et al., 1997b), and TNF-receptor-2 (Lucas et al.,
1997) have also been described as being resistant to
disease. C57BL6 mice, genetically predisposed towardSummary
TH1-dominated responses (Scott et al., 1989), are sus-
ceptible to the murine cerebral malaria syndrome,NKT cells are specialized cells coexpressing NK and
T cell receptors. Upon activation they rapidly produce whereas BALB/c mice, with a genetically determined
bias toward TH2 responses (Scott et al., 1989), are resis-high levels of interferon- (IFN-) and interleukin-4
(IL-4) and are therefore postulated to influence TH1/ tant (de Kossodo and Grau, 1993). Thus, susceptibility
to experimental cerebral malaria in mice is dependentTH2 immune responses. The precise role of the CD1/
NKT cell pathway in immune response to infection on the production of proinflammatory and counterregu-
latory cytokines by T cells and the innate immune systemremains unclear. We show here that CD1d-restricted
NKT cells from distinct genetic backgrounds differen- (de Kossodo and Grau, 1993; Grau et al., 1986).
Because cytokine levels become elevated systemi-tially influence TH1/TH2 polarization, proinflammatory
cytokine levels, pathogenesis, and fatality in the P. cally very early during infection with P. berghei, it is
reasonable to propose that nonconventional lymphoidberghei ANKA/rodent model of cerebral malaria. The
functional properties of CD1d-restricted NKT cells populations capable of acting with accelerated kinetics
may be the source of rapid and high level cytokine outputvary according to expression of loci of the natural killer
complex (NKC) located on mouse chromosome 6, involved in controlling pathology. The identity of such
lymphoid sources, however, remains unclear. CD1d-which is shown here to be a significant genetic deter-
minant of murine malarial fatalities. restricted NKT cells are a novel T cell lineage with un-
usual features (Arase et al., 1992). Upon antigen-specific
or polyclonal stimulation through the TCR, CD1d-Introduction
restricted NKT cells produce large amounts of IL-4 and
IFN- with rapid kinetics (Yoshimoto and Paul, 1994).About 2.5 million people die of severe Plasmodium falci-
parum malaria every year (World Health Organization, They have therefore been postulated to influence TH1/
TH2 differentiation of the acquired immune system (Por-1992). These fatalities are associated with a spectrum
of discrete and overlapping disease syndromes of com- celli, 1995). However, there is little evidence to date
in support of this important proposition. Indeed, theplex etiologies. Humans affected by malaria may suffer
systemic, single-, or multi-organ involvement, including functional significance of the CD1/NKT cell pathway in
the immune response to infection is still controversial,acute respiratory distress, coagulopathy, shock, meta-
bolic acidosis, hypoglycemia, renal failure, pulmonary as there are few reports to date of clear function for this
population in infection models. CD1d-restricted NKTedema, and cerebral involvement including seizures and
coma (White and Ho, 1992). Basic mechanisms control- cells have been described to have a role in resistance
ling these processes are thought to be the site-specific to Toxoplasma gondii (Denkers et al., 1996) and Leish-
localization of parasites by adherence to vascular endo- mania major (Ishikawa et al., 2000), and to increase
thelial markers such as the adhesin ICAM-1 (Berendt susceptibility to Salmonella (Naiki et al., 1999) and Liste-
et al., 1989) and both local and systemic inflammatory ria monocytogenes (Emoto et al., 1995). In this study
responses arising from the action of cytokines. we sought to investigate the role of CD1-restricted NKT
Plasmodium berghei ANKA murine malaria has many cells in the inflammatory cascade leading to P. berghei-
features in common with the human disease and is thus mediated cerebral malaria. We found that the CD1d/NKT
an accepted model for certain important aspects of cli- cell pathway differentially regulates TH1/TH2 polarization,
nical malaria (Miller et al., 2002). It manifests a cyto- malarial pathogenesis, and fatality according to the ge-
kine-dependent encephalopathy associated with up- netic background of the host. We further show that the
regulation of adhesins on the cerebral microvascular natural killer complex (NKC) located on mouse chromo-
endothelium and attendant neurological complications some 6 also regulates NKT cell function, malarial patho-
(Grau et al., 1987, 1989; Jennings et al., 1997). Particu- genesis, and fatality. These loci account in part for the
differential susceptibility of C57BL6 and BALB/c mice
to the P. berghei cerebral malaria syndrome.*Correspondence: hansen@wehi.edu.au
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Figure 1. CD1d-Restricted NKT Cells Partially Control Resistance and Susceptibility of Mice to Experimental Cerebral Malaria
WT (closed circles) or mutant mice (open circles) were infected with P. berghei ANKA. The percentage survival of BALB/c and CD1/ BALB/c
mice (A), C57BL6 and CD1/ C57BL6 mice (B), and C57BL6 and J281/ C57BL6 mice (C) was monitored daily. Parasitemia of BALB/c and
CD1/ BALB/c mice (D), C57BL6 and CD1/ C57BL6 mice (E), and C57BL6 and J281/ C57BL6 mice (F) was assessed from Giemsa-
stained blood films. Each point represents the mean parasitemia SE of the surviving animals. Each infection is representative of at least
four separate experiments. p 0.02, 0.03, and 0.05 for (A), (B), and (C), respectively, by Cox-Mantel logrank transformation. (G) Histological
examination of brains from C57BL6 WT (left panel), CD1/ BALB/c (center panel), and BALB/c WT mice (right panel) infected with P. berghei.
Magnification, 400.
Results against cerebral malaria in this genetic background (Fig-
ure 1B). C57BL6 J281/ mice lack the invariant V14
T cell receptor (TCR) chain and therefore are specificallyThe CD1d/NKT Cell Pathway Partially Controls
Resistance and Susceptibility of Mice deficient in V14 NKT cells (Cui et al., 1997). When
these mice were challenged with P. berghei ANKA, theyto Experimental Cerebral Malaria
To investigate the contribution of CD1d-restricted NKT also showed a significant (p 0.05) delay in the disease
onset compared to WT controls (Figure 1C), validatingcells to the pathogenesis of experimental cerebral ma-
laria, mice lacking CD1.1 and CD1.2 (CD1/) on both the observations in an independent mutant system and
demonstrating a role for the V14 NKT population inthe disease-resistant BALB/c and disease-susceptible
C57BL6 backgrounds, and wild-type (WT) controls, were promoting the disease susceptibility of C57BL6 mice.
Parasitemia levels were not affected by deletion of CD1challenged with P. berghei ANKA, and the course of
disease was monitored. Unlike BALB/c WT mice, or J281 in either genetic background (Figures 1D–1F).
Therefore, control of malarial fatalities by CD1d-BALB/c CD1/ mice developed cerebral malaria (p 
0.02), and 60% of the animals died between days 7 to restricted NKT cells does not operate through effects
on parasite growth rates.10 postinfection (p.i.) (Figure 1A). This CD1d deficiency
associated with increased susceptibility to disease sug- The diagnoses of cerebral malaria were confirmed by
histological examination of brains taken at various timesgests that in BALB/c mice the CD1/NKT pathway pro-
vides protection against cerebral malaria. In marked p.i. Mice dying of cerebral syndrome displayed typical
pathology including high levels of vascular occlusioncontrast, CD1d-restricted NKT cells appear to play a
modest role in promoting disease in C57BL6 mice, as with both parasitized erythrocytes and macrophages
(Figure 1G). This pathology was particularly pronouncedlack of CD1 partially but significantly (p0.03) protected
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Figure 2. CD1d-Restricted NKT Cells Significantly Control Produc-
tion of Proinflammatory Cytokines In Vivo in P. berghei-Induced
Cerebral Malaria
BALB/c (A and C) and C57BL6 (B and D) mice were infected with
P. berghei ANKA. IFN- (A and B) and TNF- (C and D) levels in
sera collected at different time points postinfection from WT (closed
circles) or CD1/ (open circles) mice were measured by capture
ELISA. Each experiment is representative of at least three separate
infections. Each point represents the mean SE. * p  0.05, ** p 
0.01 between WT and CD1/ mice.
Figure 3. The CD1/NKT Pathway Influences the TH1/TH2 Polarization
in Response to Malaria
CD4 T cells from P. berghei ANKA-infected BALB/c WT (closedin C57BL6 mice and was also present, although with
circles) or CD1/ (open circles) mice were stimulated for 3 daysreduced severity, in BALB/c CD1/ animals. BALB/c
with P. berghei ANKA total lysate (A, C, and E) or anti-CD3 (B, D,
WT mice in contrast showed absent or very much re- and F). Cells from WT (closed triangles) and CD1/ animals (open
duced vascular occlusion despite similar parasite bur- triangles) were cultured in medium alone as background controls.
dens (Figure 1G). Thus, the presence and severity of Cell proliferation was determined by [methyl-3H]-thymidine incorpo-
ration (A and B), and IFN- (C and D) and IL-4 (E and F) levelshistological markers of cerebral disease correlate well
in cell culture supernatant by capture ELISA. Each experiment iswith the overall fatality rates in these groups.
representative of at least three separate infections. Each point repre-
sents the mean of three samples SE. * p  0.05, ** p  0.01, ***
p  0.005 between stimulated cells from WT and CD1/ mice.The CD1d/NKT Cell Pathway Controls Production
of Proinflammatory Cytokines In Vivo
in Murine Cerebral Malaria to regulate systemic levels of two proinflammatory cyto-
kines associated with murine malarial pathogenesis,TNF- and IFN- are two proinflammatory cytokines as-
sociated with the development of murine cerebral ma- with opposing activities depending on the genetic back-
ground of the host.laria (Grau et al., 1987, 1989). To study whether CD1d-
restricted NKT cells regulate the serum levels of these
two cytokines in experimental cerebral malaria, sera The CD1d/NKT Cell Pathway Controls the TH1/TH2
Balance in Response to Malarial Infectionwere collected from BALB/c and C57BL6 WT or CD1/
mice at different time points p.i., and the cytokine levels Based on rapid and high output of IL-4 and IFN-, the
CD1/NKT pathway has been proposed to influence thewere assessed by capture ELISA. Disease-resistant
BALB/c WT mice had negligible levels of serum TNF- regulation of TH1/TH2 immune responses (Porcelli, 1995).
To investigate whether the differential susceptibility toand IFN- throughout the course of infection (Figures
2A and 2C). In contrast, TNF- and IFN- levels were cerebral malaria in BALB/c and C57BL6 mice reflected
the ability of CD1d-restricted NKT cells to influence thesignificantly higher in more susceptible BALB/c CD1/
mice at day 5 p.i. (Figures 2A and 2C). IFN- was lower TH1/TH2 balance in response to infection, we examined
cytokine production by CD4 cells isolated from in-in the more resistant CD1/ C57BL6 as compared with
fully susceptible WT C57BL6 mice (Figure 2B). Although fected WT and CD1/ mice. At early stages of the infec-
tion, CD4 cells from mice with increased susceptibilityshowing a trend to reduced TNF- levels in CD1/
C57BL6 mice, these results were not significantly differ- to disease, such as CD1/ BALB/c, proliferated strongly
in response to parasite antigen (Figure 3A) whereasent (Figure 2D). Thus, CD1d-restricted NKT cells appear
Immunity
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CD4 cells from WT mice did not proliferate above back-
ground controls. CD4 cells from CD1/ mice secreted
significantly higher levels of IFN- at day 3 p.i. (Figure
3C) compared with disease-resistant BALB/c WT con-
trols. No significant differences between BALB/c WT or
CD1/ mice were detected in the parasite-specific IL-4
production (Figure 3E). After day 7 postinfection, the
parasite-induced cell death among antigen-specific
lymphocytes reported previously (Hirunpetcharat and
Good, 1998) results in a depleted and apparently anergic
T cell response, and antigen-specific cytokine and pro-
liferative responses become difficult to elicit in vitro.
To investigate the impact of CD1d-restricted NKT
cells on global T cell responses, CD4 cells from BALB/c
WT and CD1/ mice were stimulated with anti-CD3
antibody. Proliferative responses decreased as the in-
fection developed (Figure 3B), indicating progressive T
cell anergy associated with malaria infection. CD4 cells
from both WT and CD1/ BALB/c mice produced high
levels of IFN- in response to anti-CD3 antibody during
the initial stages of the infection. From day 7 onward,
IFN- levels decreased in BALB/c WT but remained high
in CD1/ mice (Figure 3D). In contrast, IL-4 production
was initially downregulated but markedly increased from
day 7 postinfection, demonstrating a switch from TH1 to
TH2 immune response in BALB/c WT mice. This initial
downregulation during early time points followed by re-
covery of IL-4 production was a reproducible feature of
infection in several replicate experiments. Interestingly,
in the more susceptible BALB/c CD1/ mice, IFN-
production was not downregulated, and no switch to
IL-4 production was observed (Figures 3D and 3F), indi-
Figure 4. The CD1/NKT Pathway Influences the TH1/TH2 Polarizationcating that BALB/c CD1d-restricted NKT cells provide
in Response to Malariahelp for the development of TH2 immune responses.
CD4 T cells from P. berghei ANKA-infected C57BL6 WT (closedIn contrast to BALB/c mice, CD1d-restricted NKT cells
circles) or CD1/ (open circles) mice were stimulated for 3 dayspromote both proliferative responses and IFN- produc-
with P. berghei ANKA total lysate (A, C, and E) or anti-CD3 (B, D,
tion in WT C57BL6 mice, as partially protected C57BL6 and F). Cells from WT (closed triangles) and CD1/ animals (open
CD1/ mice showed reduced antigen-specific (Figure triangles) were cultured in medium alone as background controls.
4A) as well as anti-CD3 mediated (Figure 4B) proliferative Cell proliferation was determined by [methyl-3H]-thymidine incorpo-
ration (A and B), and IFN- (C and D), and IL-4 (E and F) levelsresponses and reduced IFN- levels at early time-points
in cell culture supernatant by capture ELISA. Each experiment isp.i. compared to WT animals (Figures 4C and 4D). No
representative of at least three separate infections. Each point repre-significant differences in IL-4 output were found be-
sents the mean of three samples SE. * p  0.01, ** p  0.005
tween CD4 cells from C57BL6 WT or CD1/ mice (Fig- between stimulated cells from WT and CD1/ mice.
ures 4E and 4F).
Control of Malarial Pathogenesis by the Natural bility to cerebral malaria we made use of NKC homozy-
gous congenic BALB.B6-Cmv1r mice, in which the re-Killer Complex
Figures 1–4 indicate that the regulatory role of CD1- gion of chromosome 6 containing the NKC from C57BL6
has been introduced onto the BALB/c background (Fig-restricted NKT cells differs markedly between BALB/c
and C57BL6 mice. Both NK and NKT cells from C57BL6 ure 5C). We also utilized the reverse congenic B6.BALB-
Cmv1s mice, in which C57BL6 background animals bearand BALB/c mice are known to differ in expression of
loci encoded by the NKC (Scalzo et al., 1999). Located a 1.5 cM region expressing the NKC of BALB/c mice
(Scalzo et al., 1995, 1999). Unlike BALB/c WT mice,on mouse chromosome 6, the NKC comprises several
genes (e.g., Cd69 and Cd94) and multigene families BALB.B6-Cmv1r congenic animals which express the
C57BL6 NKC developed cerebral malaria, and 50% of(Nkrp1, Nkg2, and Ly49) involved in the activation and
inhibition of NK cells. All NKC genes described so far the animals died between days 7 and 9 p.i. In contrast,
B6.BALB-Cmv1s mice were partially protected againstencode type II integral membrane proteins with C-lectin
domains having inhibitory or activation activity on cyto- disease compared to C57BL6 WT mice (Figures 5A and
5B). Parasitemia levels were not significantly differentkine production depending on the presence or absence
of immunoreceptor tyrosine-based inhibitory motifs in between WT and congenic mice (data not shown). In
addition, histological examination of brains taken fromtheir intracellular domains. Therefore, NKC products are
candidate regulators of malarial pathogenesis. To study BALB.B6-Cmv1r animals revealed a typical histological
profile consisting of cerebral vasculature occluded withwhether the NKC genotype can influence the suscepti-
Control of Malarial Pathogenesis by NKT Cells
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Figure 5. Control of Malarial Pathogenesis by the NKC
(A and B) Groups of 10–12 BALB/c, C57BL6, BALB.B6-Cmv1r, and B6.BALB-Cmv1s mice were infected with P. berghei ANKA. The percentage
survival was monitored daily.
(C) Map of the distal region of mouse chromosome 6 in the BALB.B6-Cmv1r mouse strain. The region inherited by the congenic mice from
the C57BL6 background is indicated in gray.
(D) BALB.B6-Cmv1r mice were depleted of NK cells by i.v injection with anti-asialo GM1 antibody. NK cell depletion was confirmed by FACS.
(E) Groups of ten anti-asialo GM1-treated and control BALB.B6-Cmv1r mice were infected with P. berghei ANKA and percentage survival was
monitored daily.
(F) BALB/c mice were injected i.v. with 6.5  105 CD44V8 cells (sorted as shown in Figure 7A) from malaria-infected BALB.B6-Cmv1r
animals, and BALB.B6-Cmv1r mice received CD44V8 cells from malaria-infected BALB/c wild-types. Adoptively transferred mice and
controls were then challenged with P. berghei ANKA. The percentage survival was monitored daily.
both parasitized erythrocytes and macrophages as NK cells without affecting NKT cells (Smyth et al., 2001).
Depletion of NK cells in BALB.B6-Cmv1r mice, con-found previously in BALB/c CD1/ mice (data not
shown). Thus, the NKC is a significant determinant of firmed by FACS analysis (Figure 5D), did not reverse
their increased susceptibility to cerebral malaria (p 	murine cerebral malaria and, in common with the CD1d/
NKT pathway, imparts either protective or disease- 0.38) (Figure 5E). To further investigate whether the ex-
pression of NKC markers influences the regulation ofenhancing properties depending on genotype.
NKC loci are expressed on NK cells as well as NKT malarial pathogenesis by NKT cells, CD44V8 NKT
cells from BALB.B6-Cmv1r or BALB/c infected donorscells. To determine which population was responsible
for mediating NKC-dependent regulation of malarial (purified by FACS sorting) were adoptively transferred
into naive recipient mice. CD44V8 cells frompathogenesis, BALB.B6-Cmv1r mice were treated with
anti-asialoGM1 antibody, known specifically to deplete BALB.B6-Cmv1r mice transferred into BALB/c recipients
Immunity
396
Figure 6. Expansion of Splenic NKT Cells in Response to P. berghei ANKA Infection
(A) Spleen cells from naive or infected BALB/c and BALB.B6-Cmv1r mice were stained with anti-CD44 and anti-V8TCR antibodies (top and
center panels). BALB.B6-Cmv1r splenocytes were also stained with anti-NK1.1 and anti-TCR antibodies (bottom panel).
(B) BALB.B6-Cmv1r splenocytes were stained with CD1d -GalCer tetramer and anti-TCR antibodies. The expression of NK1.1 cells was
analyzed in the double-positive population indicated.
(C and D) BALB.B6-Cmv1r splenocytes were stained with anti-NK1.1 and anti-TCR antibodies (C) or with anti-CD44 and anti-V8TCR
antibodies (D). The expression of U52A-13, CD4, CD8, and CD4/CD8 positive cells was analyzed in the double-positive populations (shaded
histograms). Empty histograms represent staining in gated NK1.1 or V8 T cells.
(E) The absolute number -GalCer tetramer-TCR and NK1.1TCR or CD44V8 subsets in the spleens of malaria infected or naive
BALB.B6-Cmv1r mice. Each bar represents the mean of three to five mice SE. * p  0.05, ** p  0.005 between cells from infected mice
and controls.
increased their susceptibility to P. berghei-mediated ce- the spleens of infected BALB.B6-Cmv1r mice (to 10.6%)
rebral malaria (Figure 5F). In contrast, CD44V8 cells compared to noninfected (2.9%) control animals (Figure
from malaria-infected BALB/c mice were able to transfer 6A) reaching a peak at day 5 p.i. To undertake further
partial resistance to BALB.B6-Cmv1r animals (Figure phenotyping, splenocytes from BALB.B6-Cmv1r naive
5F). As predicted, the reversal of phenotypes was partial, and infected (day 5 p.i.) mice were stained with various
due possibly to the competing contribution of resident antibodies and with CD1d -Galactosylceramide
NKT cells in recipients. Thus, NKC expression on NKT (-GalCer) tetramers. The absolute number of CD1d
cells may be responsible for the increased susceptibility -GalCer tetramer TCR NKT cells doubled in re-
to disease of BALB.B6-Cmv1r mice. sponse to malarial infection (Figure 6E). The relative
proportion of TCR CD1d -GalCer tetramer cells,
however, did not change in spleens of infected miceA Heterogeneous NK1.1 TCR Population
compared to controls (Figure 6B). Interestingly, althoughExpands in Response to P. berghei Infection
splenic CD1d -GalCer tetramer cells were expanded,We sought to determine whether NKT cells were ex-
the proportion of these cells that were NK1.1 waspanded in response to P. berghei infection. Figure 6A
slightly reduced in infected animals (Figure 6B). We alsoshows a 70% and 100% increase in the percentage of
gated NK1.1TCR (Figure 6C) or V8CD44 cellsV8CD44 cells in the spleens of BALB/c and
(Figure 6D) from naive and infected BALB.B6-Cmv1rBALB.B6-Cmv1r mice, respectively, at day 3 p.i. The
percentage of NK1.1TCR cells increased greatly in mice (day 5 p.i) and examined expression of the pan NK-
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NKT cell marker U5A2-13, CD4, and CD8. The relative CD44V8. CD44V8cells from BALB.B6-Cmv1r
mice displayed nearly three times higher IFN- levelsproportions of U5A2-13 (60%–80%), CD4 (60%–70%),
and DN cells (20%–30%) were similar in spleens from than cells from BALB/c mice (Figure 7G). IL-4 responses
were in general low, and no differences were found be-naive and infected mice (Figures 6C and 6D). However,
the absolute number of these NKT cell subsets substan- tween BALB/c and BALB.B6-Cmv1r mice. Similar results
were obtained when intracellular cytokines were ana-tially increased in response to infection (Figure 6E). Both
the percentage and absolute number of CD8 cells lyzed on gated U5A2-13TCR cells (data not shown).
Thus, in malaria infection, expression of C57BL6 NKCamong the NK1.1TCR and V8CD44 cells were
significantly higher in infected compared to noninfected markers predisposes NKT cells to increased IFN- pro-
duction. These data are highly concordant with the prop-control mice (Figures 6C–6E), although this expansion
was not alone sufficient to account for the absolute osition that differential expression of NKC loci may ac-
count in part for the differential immunological behaviorincrease in these populations. CD8 T cells, carrying the
TCR V8, have been previously described to expand of the CD1/NKT cell pathway in C57BL6 and BALB/c
mice.in response to malaria infection (Boubou et al., 1999).
Taken together, these results indicate that a heteroge-
neous NK1.1TCR population including conven- Discussion
tional and nonconventional NKT cells as well as CD8 T
lymphocytes expands in response to malaria infection. This study shows that CD1d-restricted NKT cells influ-
ence the TH1/TH2 balance, pathogenesis, and fatality in
murine cerebral malaria, and cells from distinct geneticThe NKC Phenotype Influences the Capacity
of NKT Cells to Secrete Cytokines backgrounds appear to have opposing properties in this
regard. The CD1/NKT cell pathway appears to favorTo determine whether NKC phenotype can directly influ-
ence the capacity of NKT cells to secrete cytokines, the development of TH2 polarization and resistance to
cerebral malaria in BALB/c mice, and induces earlyV8CD44 NKT cells were isolated by FACS sorting
from splenocytes of BALB/c, C57BL6, and BALB.B6- IFN- production and promotes pathology in suscepti-
ble C57BL6 animals. CD1d-restricted NKT cells clearlyCmv1r mice (Figure 7A). The cells were then stimulated
for 4 days with plate-bound anti-CD3 or anti-NK1.1 anti- influence the overall production of IFN- and TNF- in
vivo during malaria infection. The differential expressionbodies. When sorted V8CD44 cells were cultured
with anti-CD3, they secreted high levels of both IL-4 and of molecules encoded by the NKC may account in part
for the opposing roles of NKT cells in C57BL6 andIFN- (Figures 7B and 7C). Stimulation with anti-NK1.1
antibody induced only IFN- production but no IL-4 in BALB/c mice in response to P. berghei infection. Our
data, moreover, indicate that the NKC is a significantNKT cells from C57BL6 and BALB.B6-Cmv1r mice (Fig-
ures 7B and 7C). Thus, stimulation through the TCR genetic determinant of murine cerebral malaria, im-
parting partial protection or susceptibility depending onresults in comparable levels of both IFN- and IL-4 out-
put in BALB/c and C57BL6 mice. However, activation of genotype.
Throughout this study, the most pronounced effectsNKC receptors such as NK1.1 expressed in the C57BL6
background preferentially induces IFN- production. in relation to both CD1d-restricted NKT cells and the
NKC in protection against cerebral malaria were ob-To investigate whether the NKC phenotype also influ-
ences the ability of NKT cells to secrete cytokines in served on the BALB/c background, compared with a
smaller but significant and reproducible effect in pro-response to malaria infection, sorted V8CD44 (Fig-
ure 7A) cells from P. berghei-infected BALB/c and moting disease susceptibility and TH1 responses in
C57BL6 mice. This differential penetrance presumablyBALB.B6-Cmv1r mice were stimulated with -GalCer,
and proliferative responses and IL-4 and IFN- produc- reflects a relatively greater contribution by other suscep-
tibility loci in the latter case, i.e., it seems likely thattion were analyzed. V8CD44 cells from both BALB/c
and BALB.B6-Cmv1r mice proliferated in response to additional pathways or loci promote disease susceptibil-
ity in C57BL6 mice.-GalCer, confirming the presence of V14 NKT cells
within that population (Figure 7D). In both mouse strains, Previous studies in rodent malaria infections show
that an initial TH1 response switches after the first weekcell proliferation decreases as the infection develops,
suggesting that CD1d-restricted NKT cells do not evade to a TH2 response (Langhorne et al., 1989; Taylor-Rob-
inson et al., 1993). The sequential onset of TH1-mediatedthe progressive T cell anergy associated with malaria
infection. Like cell proliferation, cytokine output gradu- cellular mechanisms and TH2-mediated antibody re-
sponses is proposed to be necessary for the immuno-ally decreases in response to infection. -GalCer-stimu-
lated NKT cells from both infected BALB/c and logical control of Plasmodium blood stage infections.
Our data indicate that a similar process occurs in P.BALB.B6-Cmv1r mice produced similar levels of IL-4
(Figure 7E). By days 7 and 10 p.i., however, BALB/c NKT berghei-infected disease-resistant BALB/c mice and
that this is regulated by CD1d-restricted NKT cells. Incells cease IFN- production almost entirely. In contrast,
NKT cells from BALB.B6-Cmv1r mice continued to se- this case, the switch from TH1 to TH2 immune responses
may downregulate the strong proinflammatory responsecrete around 15 times more IFN- than NKT cell from
BALB/c mice (Figure 7F). The ex vivo cytokine produc- involved in the cerebral syndrome, explaining a protec-
tive role against disease for CD1d-restricted NKT cellstion by NKT cells from infected mice was also analyzed.
To that end, splenocytes from infected mice were in BALB/c mice. These findings from an infectious dis-
ease are consistent with data from a TH1-driven autoim-stained with anti-CD44 and anti-V8, and intracellu-
lar IL-4 and IFN- were analyzed by FACS on gated mune condition, where adoptive transfer or overexpres-
Immunity
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Figure 7. The NKC Phenotype Influences the Capacity of NKT Cells to Secrete Cytokines
(A) The V8CD44 population of splenic NKT cells was purified by FACS sorting from splenocytes of BALB/c, C57BL6, and BALB.B6-Cmv1r
mice. The purified NKT cells were stimulated for 4 days with plate-bound anti-CD3, anti-NK1.1, or medium alone.
(B and C) IFN- (B) and IL-4 (C) levels were measured in cell culture supernatants by ELISA. Each bar represents the mean of three samplesSE.
* p  0.05 between BALB/c and C57BL6 or BALB.B6-Cmv1r mice.
(D–F) V8CD44 NKT cells from P. berghei-infected BALB/c and BALB.B6-Cmv1r mice were stimulated with -GalCer for 4 days. Cell
proliferation was determined by [methyl-3H]-thymidine incorporation (D), and IL-4 (E) and IFN- (F) levels in cell culture supernatant by capture
ELISA. Each bar represents the mean of three samples SE. * p  0.05, ** p  0.01, *** p  0.005 between cells from -GalCer-stimulated
BALB/c and BALB.B6-Cmv1r mice.
(G) Ex vivo cytokine production by NKT cells. Splenocytes from BALB/c and BALB.B6-Cmv1r malaria infected-mice were stained with anti-
CD44 and anti-V8TCR antibodies, and intracellular IL-4 or IFN- was analyzed by FACS. Representative histograms from cells gated on
CD44V8 are shown. The dotted lines represent cytokine staining from infected mice (day 7), and the full lines show noninfected controls.
sion of NKT cells in nonobese diabetic (NOD) mice tes (Godfrey et al., 1997; Wilson et al., 1998), and CD1/
NOD mice are more susceptible to the disease (Shi etprotects against diabetes (Hammond et al., 1998; Leh-
uen et al., 1998). Furthermore, defects in NKT cell num- al., 2001).
Genetically determined resistance to murine cyto-ber and function occur in murine and human type I diabe-
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megalovirus (MCMV) is controlled by a gene designated of the immune system and provides a framework
Cmv1 that regulates MCMV replication in the spleens allowing the characterization of the NKT cell function
of mice (Scalzo et al., 1995). C57BL6 mice express the under physiological conditions. This model provides evi-
Cmv1r allele and are resistant to this condition whereas dence that NKT cells can be stimulated by pathways
BALB/c mice express the Cmv1s allele and show high other than the TCR and that the genetic background of
viral titers. Generation of congenic mouse strains has the host influences the regulatory impact of NKT cells
allowed the mapping of these alleles to the NKC located on the global immune response. Moreover, this study
on the distal region of mouse chromosome 6. Recent and other infection models including Leishmania major
studies show that Cmv1r maps to the NK activation re- (Ishikawa et al., 2000), Hepatitis B virus (Baron et al.,
ceptor Ly49H (Dokun et al., 2001). Molecules encoded 2002), Crytococcus neoformans (Kawakami et al., 2001),
by the NKC include different receptors involved in the and Salmonella (Naiki et al., 1999) indicated that NKT
activation or inhibition of NK cells. They are all type cell populations become highly expanded in response
II integral proteins with C-lectin domains. The NK1.1 to infection. In contrast, stimulation with glycolipids like
alloantigen is an activation receptor. Its function is still -GalCer results in strong TCR-driven NKT cell activa-
unknown but it has been shown that stimulation with tion (Kawano et al., 1997), followed by massive NKT
anti-NK1.1 antibody induces NK cell-mediated cytotox- cell death and homeostatic replacement from the bone
icity and cytokine production (Karlhofer and Yokoyama, marrow (Eberl and MacDonald, 2000). It is therefore pos-
1991). Furthermore, this report and others (Arase et al., sible that stimulation of NKT cells with physiological
1996) show that crosslinking of NK1.1 preferentially in- ligands expressed during viral, bacterial, or parasitic
duces IFN- and no IL-4 production by CD1d-restricted infections results in alternative or additional activation
NKT cells, raising the possibility that carbohydrate rec- pathways. Studies aimed at identification and character-
ognition by these cells is involved in upregulation of ization of NKT cell natural ligands are necessary to ad-
proinflammatory responses by a TCR-independent dress this proposition.
pathway. Other multigene families encoded within the In addition to -GalCer, CD1d-restricted NKT cells
NKC include Ly49 and NKG2 receptors. Protein prod- recognize GPIs of parasite origin when these agents are
ucts encoded by these genes are responsible for the supplied as exogenous antigens (Schofield et al., 1999)
recognition of MHC class I molecules on potential target but not when expressed as endogenous ligands within
cells and subsequent inhibition or activation of cytotoxic the antigen-presenting cell (Molano et al., 2000). Malarial
activity (Lanier, 1998). Stimulation of activation recep- GPI comprises greater than 95% of plasmodial carbohy-
tors such as Ly49D (Mason et al., 2000) and Ly49H (Do- drate, is the main posttranslational modification of para-
kun et al., 2001) leads to IFN- secretion. Moreover, a site antigens (Gowda et al., 1997), and is therefore a
recent study demonstrated that a subset of NKT cells reasonable candidate antigenic stimulus for NKT cells
expressing high levels of NKG2d selectively produces in malaria infection. NKT cells may be influenced toward
IFN- and TNF- (Gumperz et al., 2002). Together, this a TH2 polarized cytokine profile by immunization with
evidence suggests that expression of NKC markers on -GalCer (Burdin et al., 1999; Singh et al., 1999). These
NKT cells might provide additional pathways for induc- considerations raise the possibility of reducing suscepti-
tion of TH1-like responses. bility to severe malarial disease in human populations
Most malaria susceptibility/resistance loci described by immunomodulation via a TH2-biased, CD1-restricted
in humans are involved in the control of parasite replica- glycolipid vaccine.
tion. In murine systems, a congenic study has defined
a role for MHC loci in determining resistance to P. cha- Experimental Procedures
baudi infection (Wunderlich et al., 1988). Quantitative
trait locus (QTL) analyses on genome scans from murine Mice and Infections
Eight- to twelve-week-old BALB/c, BALB/c CD1/ (F10 generationintercrosses identify alleles on chromosomes 8 and 9
[Smiley et al., 1997]), C57BL6, C57BL6 CD1/ (F6 generation [So-(char1 and char2) with 30%–40% penetrance in control-
noda et al., 1999]), C57BL6 J281/ (F9 generation [Cui et al., 1997]),ling P. chabaudi replication (Foote et al., 1997; Fortin et
BALB.B6-Cmv1r (F6 generation [Scalzo et al., 1995]), andal., 1997). The present study uses congenic mice to B6.BALBCmv1s (F6 generation [Scalzo et al., 1999]) mice were used
establish one or more NKC loci on mouse chromosome throughout the study. The BALB.B6-Cmv1r and B6.BALBCmv1s
6 exerting 40%–50% penetrance in the control of P. mice were backcrossed using speedy marker-assisted congenic
berghei-induced pathogenesis and fatality through mapping methods. Groups of 10–15 BALB/c WT, BALB/c CD1/,
BALB.B6-Cmv1r, and B6.BALBCmv1s were injected i.p. with 1 mechanisms independent of parasite replication. The
106, and C57B/6 WT, C57B/6 CD1/, and J281/ mice receivedmurine NKC and human syntenic regions constitute sig-
1  104, P. berghei ANKA-infected erythrocytes. In some experi-nificant regulatory components of innate immunity, ex-
ments, mice were injected i.v. with 20
g of anti-asialo GM1 antibody
hibiting a high level of functional polymorphisms in both (Wako, Osaka, Japan) 6 hr before challenge in order to deplete
species. This evidence therefore allows formulation of NK cells. NK cell depletion was confirmed by flow cytometry. For
the testable hypotheses that syntenic human chromo- adoptive transfer experiments, mice were injected i.v. with 6.5 
somal regions corresponding to char1, char2, and the 105 CD44V8 cells purified from infected mice (day 7 p.i.) by FACS
sorting as described below. Control mice received saline. Four hoursNKC may be associated with resistance or susceptibility
later, adoptively transferred mice and controls were challenged withto pathogenesis and fatalities in human malaria.
P. berghei ANKA. Parasitemia was assessed from Giemsa-stainedMuch useful evidence to date concerning NKT cell
smears of tail blood prepared every 2–3 days. Mortality was checked
function in vivo is provided by the exogenous adminis- daily. Mice were judged as developing cerebral malaria if they dis-
tration of -GalCer (Kawano et al., 1997). However, this played neurological signs such as ataxia, loss of reflex, and hemiple-
glycolipid antigen stimulates only through the TCR. P. gia, and died between days 6 to 12 postinfection with relatively low
parasitemia. Statistical differences in mortality rates of groups of P.berghei ANKA infection induces a generalized activation
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berghei infected mice during this period of susceptibility to cerebral anti-V8 TCR-FITC-conjugated antibody (all antibodies from Phar-
mingen, San Diego, CA) for 1 hr on ice. After washing two timesmalaria were assessed by Cox-Mantel logrank analysis. All experi-
ments were performed in compliance with local Animal Ethics Com- with PBS, double-positive cells were isolated by flow cytometry.
The purified cells were seeded in triplicates in 96-well plates at amittee requirements.
density of 3  104 cells and stimulated with plate-bound anti-CD3
(10 
g/ml), plate-bound anti-NK1.1 (100 
g/ml), or with -GalCer,Histology
(50 ng/ml) for 4 days. -GalCer was kindly provided by the Pharma-For histological analysis of cerebral pathology, brains were taken
ceutical Research Laboratories, Kirin Brewery (Gumna, Japan). Ininto 10% neutral-buffered formalin, sectioned (5 
m), and stained
-GalCer-stimulated cultures, naive syngeneic spleen cells depletedwith hemotoxylin and eosin. Slides were coded and scored blind
of T cells with Dynabeads (Dynal Biotech, Norway) and irradiatedfor histological evidence of cerebral syndrome.
to 3000 rads were added as antigen-presenting cells at a density
of 2  106 cells/ml. Cells cultured in medium alone were used asLymphoproliferative Assays
background controls. [Methyl-3H]-thymidine (2 
Ci/well, 5 Ci/mmol,Spleen cells from BALB/c and C57BL6, WT and CD1/ mice (n 
Amersham, UK) was added 16 hr before harvest, and radioactivity3) were collected at different times postinfection with P. berghei
was measured in a betaplate counter. The cell culture supernatantsANKA. Splenic CD4 cells were purified by positive selection with
were collected to measure the production of IL-4 and IFN- byDynabeads following the manufacturer’s instructions (98%–99% pu-
capture ELISA.rity) (Dynal Biotech, Norway). For proliferation assays, CD4 cells
suspended in complete RPMI-1640 medium, 5% fetal calf serum,
Statistic Analysiswere seeded in 96-well plates at a density of 5  105 cells/ml.
A paired-sample Student’s t test was used for data evaluation. Dif-Naive syngeneic spleen cells irradiated to 3000 rads were added
ferences in mortality rates of P. berghei-infected mice during theas antigen-presenting cells at a density of 2  106 cells/ml. Cells
period of susceptibility were assessed by Cox-Mantel logrankwere then stimulated in triplicate for 3 days with P. berghei ANKA
analysis.total lysate (50 
g/ml) or anti-CD3 (5 
g/ml, Pharmingen, San Diego,
CA). Cells cultured in medium alone were used as background con-
Acknowledgmentstrols. [Methyl-3H]-thymidine (2 
Ci/well, 5 Ci/mmol, Amersham, UK)
was added 16 hr before harvest, and radioactivity was measured
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